US Edition
Published • loading... • Updated
Serum 25-Hydroxyvitamin D and Neurological Disability in Multiple Sclerosis: A Cross-Sectional Study from the Mediterranean Epidemiological Frontier
Summary by researchsquare.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Serum 25-Hydroxyvitamin D and Neurological Disability in Multiple Sclerosis: A Cross-Sectional Study from the Mediterranean Epidemiological Frontier
Background Vitamin D is widely studied in multiple sclerosis (MS), yet its clinical relevance for disability and relapse activity remains uncertain, especially in underrepresented populations. Objective To examine whether serum 25-hydroxyv...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
